Title : Novel Levetiracetam Derivatives That Are Effective against the Alzheimer-like Phenotype in Mice: Synthesis, in Vitro, ex Vivo, and in Vivo Efficacy Studies - Sola_2015_J.Med.Chem_58_6018 |
Author(s) : Sola I , Aso E , Frattini D , Lopez-Gonzalez I , Espargaro A , Sabate R , Di Pietro O , Luque FJ , Clos MV , Ferrer I , Munoz-Torrero D |
Ref : Journal of Medicinal Chemistry , 58 :6018 , 2015 |
Abstract :
We have synthesized a series of heptamethylene-linked levetiracetam-huprine and levetiracetam-(6-chloro)tacrine hybrids to hit amyloid, tau, and cholinergic pathologies as well as beta-amyloid (Abeta)-induced epileptiform activity, some of the mechanisms that eventually lead to cognitive deficits in Alzheimer's disease patients. These hybrids are potent inhibitors of human acetylcholinesterase and butyrylcholinesterase in vitro and moderately potent Abeta42 and tau antiaggregating agents in a simple E. coli model of amyloid aggregation. Ex vivo determination of the brain acetylcholinesterase inhibitory activity of these compounds after intraperitoneal injection to C57BL6J mice has demonstrated their ability to enter the brain. The levetiracetam-huprine hybrid 10 significantly reduced the incidence of epileptic seizures, cortical amyloid burden, and neuroinflammation in APP/PS1 mice after a 4-week treatment with a 5 mg/kg dose. Moreover, the hybrid 10 rescued transgenic mice from cognitive deficits, thereby emerging as an interesting disease-modifying anti-Alzheimer drug candidate. |
PubMedSearch : Sola_2015_J.Med.Chem_58_6018 |
PubMedID: 26181606 |
Sola I, Aso E, Frattini D, Lopez-Gonzalez I, Espargaro A, Sabate R, Di Pietro O, Luque FJ, Clos MV, Ferrer I, Munoz-Torrero D (2015)
Novel Levetiracetam Derivatives That Are Effective against the Alzheimer-like Phenotype in Mice: Synthesis, in Vitro, ex Vivo, and in Vivo Efficacy Studies
Journal of Medicinal Chemistry
58 :6018
Sola I, Aso E, Frattini D, Lopez-Gonzalez I, Espargaro A, Sabate R, Di Pietro O, Luque FJ, Clos MV, Ferrer I, Munoz-Torrero D (2015)
Journal of Medicinal Chemistry
58 :6018